This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

JR-131

JCR Pharmaceuticals Co., Ltd.

Drug Names(s): darbepoetin alfa, JR131

Description: JR-131 is a biosimilar for a long-acting erythropoiesis-stimulating agent, darbeopoetin alfa.

Deal Structure: JCR and Kissei
In 2013, JCR entered into a joint development agreement with Kissei Pharmaceutical Co.,Ltd. for follow-on biologics of long-acting erythropoiesis stimulating agent (darbopoietin alfa).

Partners: Kissei Pharmaceutical Co., Ltd


JR-131 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug